gms | German Medical Science

30. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie

09.11. - 10.11.2023, Köln

Medical drug expertise assessments in the Quality Assurance in the Medical Advisory Service Institutions in Germany

Qualitätssicherung für die Arzneimittelgutachten in den regionalen Medizinischen Diensten in Deutschland

Meeting Abstract

Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie e.V. (GAA). 30. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie. Köln, 09.-10.11.2023. Düsseldorf: German Medical Science GMS Publishing House; 2023. Doc23gaa20

doi: 10.3205/23gaa20, urn:nbn:de:0183-23gaa204

Published: November 7, 2023

© 2023 Ries et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Background: Medical expertise assessments for German in- and out-patient care performed by the Regional Medical Advisory Service Institutions have to accomplish a nationwide quality assurance plan, since public quality reporting became mandatory by national law in 2024. To err is human and occurs among medical experts, as well. Our aim is to establish a continuous mutual learning situation within a benchmark framework for a nationwide quality assurance plan covering all medical expertise assessments performed by the Medical Service Institution. This year, drug treatment reports were included as a new module in the nationwide quality assurance plan.

Materials and methods: In the German Health Care system, medical health care expertise is provided by the 15 Regional Medical Advisory Service Institutions (MD) established by the social code (SGB, Sozialgesetzbuch). All workflows are completely digitalized using mathematical IT-based procedures for randomized sampling and for an equal distribution of the medical expertise assessments to be reviewed. Our technical framework for peer review distribution, data collection and final result analysis includes a completely IT-based workflow not only masking the origin of the medical expertise assessments discussed, but routing the peer review processes in a way that independent and impartial review sheets are produced by peers that were previously not yet involved in the reviewing process. By January 2023, the rollout of the new quality assurance plan was accomplished by including new and unconventional diagnostic and therapeutic methods or medical devices, drug prescription and drug treatment. Using 19 quality criteria, the experts decide which output type in the range ‘correct’, ‘improvement potential’ and ‘incorrect’ is given.

Results: By the end of September 2024, 660 Medical expertise assessments by the Regional Medical Advisory Service Institutions and 280 external cross-over assessments performed by one of the other 14 Medical Advisory Service Institutions were available. The largest proportion of assessments concerned the off-label use of drugs, followed by new and unconventional diagnostic and therapeutic methods or medical devices and then by reviews of medical cannabinoids. A topic point of view is the comparison of the internal and the external evaluation of the expertise assessments of an MD, whereby the different quality of the expertise assessments is mainly considered. The external review is a representative mix of all other MDs over a sufficiently long period of time so that a moderate severity of the assessment is applied. There were only 2.7% extreme differences between the ‘correct’ and the ‘incorrect’ rating results.

Conclusion: The results of quality assurance will be published in great detail in accordance with the recently adopted statistics guideline. We present a valuable tool creating maximum transparency of the quality assurance outcomes and at the same time founded on positive criticism without blaming individual Institutions or individual medical experts participating. We hope that this powerful tool will ease the improvement processes. This is achieved by an insightful self-assessment and benchmarking fostering a mindful dialogue within the 15 Medical Advisory Institutions involved. Consensus-conferences are meant to be a very satisfactory and efficient quality assurance tool to ascertain high quality in the peer review process.


References

1.
Altenstetter C, Busse R. Health care reform in Germany: patchwork change within established governance structures. J Health Polit Policy Law. 2005 Feb-Apr;30(1-2):121-42. DOI: 10.1215/03616878-30-1-2-121 External link
2.
Beauchamp TL, Childress JF. Priciples of Biomedical Ethics. 5. Aufl. Oxford, UK: Oxford University Press; 2001.
3.
Bühn S, Mathes T, Prengel P, Wegewitz U, Ostermann T, Robens S, Pieper D. The risk of bias in systematic reviews tool showed fair reliability and good construct validity. J Clin Epidemiol. 2017 Nov;91:121-8. DOI: 10.1016/j.jclinepi.2017.06.019 External link
4.
Cortina J. What Is Coefficient Alpha? An Examination of Theory and Applications. Journal of Applied Psychology. 1993;78(1):98–104.
5.
Deming WE. Out of the crisis. Cambridge: Massachusetts Institute of Technology; 1982.
6.
Deutsche Rentenversicherung (DRV). Qualitätssicherung der sozialmedizinischen Begutachtung. Manual zum Peer Review-Verfahren. Überarbeitete Fassung August 2018. Berlin: Deutsche Rentenversicherung Bund; 2018.
7.
Eisinga R, Grotenhuis Mt, Pelzer B. The reliability of a two-item scale: Pearson, Cronbach, or Spearman-Brown? Int J Public Health. 2013 Aug;58(4):637-42. DOI: 10.1007/s00038-012-0416-3 External link
8.
Gerlach FM. Qualitätsförderung in Praxis und Klinik: eine Chance für die Medizin. Stuttgart: Thieme; 2001.
9.
Gostomzyk JG, Hollederer A. Angewandte Sozialmedizin. Handbuch für Weiterbildung und Praxis. Landsberg am Lech: Ecomed Medizin; 2022.
10.
Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
11.
Institute of Medicine; Committee to Design a Strategy for Quality Review and Assurance in Medicare. Medicare: A Strategy for Quality Assurance. Volume II: Sources and Methods. Washington, DC: National Academies Press; 1990.
12.
Internationale Organisation für Normung. DIN EN ISO 9001:2015-11. Qualitätsmanagementsysteme - Anforderungen. Berlin: Beuth Verlag; 2015.
13.
Kamiske GF, Brauer JP. Qualitätsmanagement von A bis Z: Wichtige Begriffe des Qualitätsmanagements und ihre Bedeutung. München: Carl Hanser Verlag; 2011.
14.
Kreuzer C, Thiele KP, Ries V. Krankenhaus - Abrechnungsprüfungen und Qualitätskontrollen. In: Hartweg HR, Knieps F, Agor K, eds. Krankenkassen- und Pflegekassenmanagement. Hintergrund, Kontext, Anwendung. Wiesbaden: Springer Gabler; 2022. p. 1-20.
15.
Masaaki I. Kaizen: The Key To Japan’s Competitive Success. New York: McGraw-Hill Education; 1986.
16.
Newman ME. Finding community structure in networks using the eigenvectors of matrices. Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Sep;74(3 Pt 2):036104. DOI: 10.1103/PhysRevE.74.036104 External link
17.
Normand SL, McNeil BJ, Peterson LE, Palmer RH. Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care. 1998 Jun;10(3):247-60. DOI: 10.1093/intqhc/10.3.247 External link
18.
Nüchtern E. Das professionelle Gutachten. Besonderheiten in der gesetzlichen Krankenversicherung. MedSach. 2008;105(3):96–8.
19.
Nüchtern E, von Mittelstaedt G. Sozialmedizin: Unabhängig und fair in der Beurteilung. Dtsch Arztebl. 2015;112(1-2):A-24/B-20/C-20.
20.
Polak UW. Evaluation von Durchgangsarztberichten mithilfe eines Peer-Review-Verfahrens. Trauma Berufskrankh. 2018;20(Suppl. 4):237–40.
21.
Ries V, Thiele K, Schuster M, Schuster R. IT-structures and Algorithms for Quality Assurance in the Health Insurance Medical Advisory Service Institutions in Germany. In: Cabitza F, Fred A, Gamboa H, editors. Proceedings of the 13th International Joint Conference on Biomedical Engineering Systems and Technologies BIOSTEC – Volume 5; 2020 Feb 24-26, 2020; Valletta, Malta. Cham: Springer Nature; 2021. p. 353-60. DOI: 10.5220/0008912303530360 External link
22.
Ries V, Thiele KP, Garbrock K, Hassa R. Medizinische Dienste ud Medizinischer Dienst Bund in der Krankenversicherung. In: Hartweg HR, Knieps F, Agor K, editors. Krankenkassen- und Pflegekassenmanagement. Hintergrund, Kontext, Anwendung. Wiesbaden: Springer Gabler; 2022. p. 1-23.
23.
Schuster R. Strukturelle Beratung der Krankenkassen durch den Medizinischen Dienst in der Pharmakotherapie - Die Verwendung epidemiologischer und gesundheitsökonomischer Analysen im Zeitalter von Digitalisierung und Big Data. In: Hartweg HR, Knieps F, Agor K, editors. Krankenkassen- und Pflegekassenmanagement. Hintergrund, Kontext, Anwendung. Wiesbaden: Springer Gabler; 2022. p. 1-40.
24.
Sawicki PT, Bastian H. German health care: a bit of Bismarck plus more science. BMJ. 2008 Nov 7;337:a1997. DOI: 10.1136/bmj.a1997 External link
25.
Schmacke N. Zur Positionierung des MDK in der gesetzlichen Kranken- und Pflegeversicherung. Gutachten im Auftrag des AOK-Bundesverbandes. Bremen: Institut für Public Health und Pflegeforschung (IPP) der Universität Bremen; 2016. (IPP-Schriften – Schriftenreihe des Instituts für Public Health und Pflegeforschung (IPP); 14).
26.
Shewhart WA. Statistical Method from the view-point of quality control (Reprint im Jahr 1986 einer Veröffentlichung des Department of Agricultuire Milwaukee 1931). New York: Dover Publication; 1931.
27.
Shinano Y, Fujie T, Kounoike Y. Effectiveness of Parallelizing the ILOG-CPLEX Mixed Integer Optimizer in the PUBB2 Framework. In: Euro-Par 2003 Parallel Processing. Heidelberg: Springer Berlin; 2003. p. 451–60.
28.
Strahl A, Gerlich C, Alpers GW, Ehrmann K, Gehrke J, Müller-Garnn A, Vogel H. Development and evaluation of a standardized peer-training in the context of peer review for quality assurance in work capacity evaluation. BMC Med Educ. 2018 Jun 13;18(1):135. DOI: 10.1186/s12909-018-1233-z External link
29.
Strahl A, Gerlich C, Wolf HD, Gehrke J, Müller-Garnn A, Vogel H. Qualitätssicherung in der Sozialmedizinischen Begutachtung durch Peer Review - ein Pilotprojekt der Deutschen Rentenversicherung [Quality Assurance in Sociomedical Evaluation by Peer Review: A Pilot Project of the German Statutory Pension Insurance]. Gesundheitswesen. 2016 Mar;78(3):156-60. DOI: 10.1055/s-0034-1390450 External link
30.
Thiele KP, Kreuzer C, Mengel R. Krankenhauslandschaft in Deutschland: Zukunftsperspektiven, Entwicklungstendenzen, Handlungsstrategien. Chapter Exkurs 3: MDK-Prüfung - Fluch oder Segen? Stuttgart: Kohlhammer; 2018. p. 89–94.
31.
Varkey B. Principles of Clinical Ethocs and Their Application to Practice. Med Princ Pract. 2021;30(1):17-28. DOI: 10.1159/000509119 External link
32.
Wirtz M, Caspar F. Beurteilerübereinstimmung und Beurteilerreliabilität: Methoden zur Bestimmung und Verbesserung der Zuverlässigkeit von Einschätzungen mittels Kategoriensystemen und Ratingskalen. Göttingen: Hogrefe; 2002.